Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion type Assertion NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_head.
- NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion description "[The frequencies of several aberrations varied with type of therapy, eg, 5q- was more frequent in radiotherapy-associated t-MDS, monosomy 7 was more common in t-AML and t-MDS after treatment with alkylators, and t(11q23) in t-AML was associated with topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_provenance.
- NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion evidence source_evidence_literature NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_provenance.
- NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion SIO_000772 12454741 NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_provenance.
- NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion wasDerivedFrom befree-2016 NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_provenance.
- NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_assertion wasGeneratedBy ECO_0000203 NP375867.RAaBBnQjOJMTdSwSGeI2KJXDYMXfMlKbdvAtXToxMRXTk130_provenance.